カテゴリー： Grand View Research, 世界, 医療/バイオ

世界の血流感染検査市場2023-2030：製品別（機器、試薬、消耗品）、サンプル種類別（血液培養）、技術別（PCR、ISH）、エンドユーザー別、地域別

◆英語タイトル：Bloodstream Infection Testing Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Sample Type (Blood Culture), By Technology (PCR, ISH), By End-user, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが発行した調査報告書（GRV23NVB032）◆商品コード：GRV23NVB032
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2023年10月18日
◆ページ数：120
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：臨床診断
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

血流感染検査市場の成長と動向

Grand View Research, Incの新しい調査によると、世界の血流感染検査市場規模は2030年までに9億7,757万ドルに達し、年平均成長率は4.5%で推移すると予測されています。例えば、欧州疾病予防管理センター（ECDC）が2022年4月に実施した疫学調査によると、欧州地域全体でカンジダ・オーリスの症例が顕著に増加しています。この調査では、2020年には8カ国から335症例が報告されていたC. aurisの報告症例が、2021年には13カ国から655症例が報告され、大幅に増加していることが明らかになりました。2021年に報告された症例の15.3%を血流感染が占めています。

また、市場の主要企業による技術の進歩や新製品の上市の増加、政府の奨励的な取り組み、献血の重要性に関する意識の高まりが、市場の成長を促進すると予想されます。例えば、2020年4月に 次世代シーケンサー企業であるDNAe社は、革新的なLiDia-SEQプラットフォームと最初のアッセイについて、米国食品医薬品局（FDA）から「画期的デバイス（Breakthrough Device）」の指定を受けました。この指定により、DNAeは感染症診断、がん、感染管理、パンデミックへの備えと対応に向けた迅速かつ費用対効果の高い検査を開発することが可能になります。指定された検査法は、感染症、特に血流感染症（BSI）と抗菌薬耐性（AMR）に焦点を当て、患者検体から直接、敗血症に関連する感染症を検出・同定することを目的としています。FDAはBreakthrough Deviceプログラムを通じて、DNAeのLiDia-SEQシーケンスシステムとBSI/AMR検査の開発と上市を促進するための継続的な支援と協力的な交流を行います。

F.ホフマン・ラ・ロシュ社、bioMérieux SA、BDなど、市場の主要企業は、製品能力を強化し、製品提供を促進するため、合併・買収戦略を実施しています。例えば、2021年5月、F.ホフマン・ラ・ロシュ社は18億米ドルでジェンマーク・ダイアグノスティックスの買収を完了しました。この買収により、ロシュは分子診断薬のポートフォリオを拡大することができます。同様に2021年12月には、血液学検査、遺伝性遺伝子検査、感染症診断、移植医療向けに約45のCE-IVD承認アッセイを有するTIB Molbiol Groupを買収しました。

血流感染検査市場レポートハイライト

- 製品別では、試薬・消耗品セグメントが2022年の市場で最大の収益シェアを占めました。また、このセグメントは、ドナーおよびレシピエントがスクリーニング製品を容易に入手でき、頻繁に購入できることから、予測期間中に最も速い速度で成長する見込みです。

- サンプルタイプ別では、血液培養セグメントが2022年に最大の収益シェアを占め、予測期間中に最も速いCAGRが見込まれます。

- 技術別では、PCR分野が2022年に最大の収益シェアを占め、検査需要の増加により予測期間中に最も速いCAGRで成長する見込みです。

- エンドユーザー別では、病院・診断センター分野が2022年に最大の収益シェアを占めました。

- 北米は血流感染検査市場を支配し、2022年に最大の収益シェアを占めました。これは、この地域の可処分所得の増加、高度に発達した医療インフラ、有利な償還政策によるものです。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変数・傾向・範囲
第4章. 血流感染検査の世界市場：製品別分析
第5章. 血流感染検査の世界市場：サンプル種類別分析
第6章. 血流感染検査の世界市場：技術別分析
第7章. 血流感染検査の世界市場：エンドユーザー別分析
第8章. 血流感染検査の世界市場：地域別分析
第9章. 競争状況
第10章. アナリストの見解

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Sample Type segment
1.1.1.2. Product segment
1.1.1.3. Technology segment
1.1.1.4. End-use segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective – 1
1.4.2. Objective – 2
1.4.3. Objective – 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Product and Sample Type Snapshot
2.3. Technology and End-use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of infectious diseases
3.2.1.2. Technological advancements in bloodstream infection testing
3.2.1.3. Growing initiatives for blood donations campaign
3.2.2. Market Restraint Analysis
3.2.2.1. High diagnosis cost and lower investments in underdeveloped countries
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Bloodstream Infection Testing Market: Product Business Analysis
4.1. Bloodstream Infection Testing Market: Product Movement Analysis
4.2. Instruments
4.2.1. Instruments Market, 2018 – 2030 (USD Million)
4.3. Reagents and Consumables
4.3.1. Reagents and Consumables Market, 2018 – 2030 (USD Million)
Chapter 5. Bloodstream Infection Testing Market: Sample Type Business Analysis
5.1. Bloodstream Infection Testing Market: Sample Type Movement Analysis
5.2. Whole Blood
5.2.1. Whole Blood Market, 2018 – 2030 (USD Million)
5.3. Blood Culture
5.3.1. Blood Culture Market, 2018 – 2030 (USD Million)
Chapter 6. Bloodstream Infection Testing Market: Technology Business Analysis
6.1. Bloodstream Infection Testing Market: Technology Movement Analysis
6.2. PCR
6.2.1. PCR Market, 2018 – 2030 (USD Million)
6.3. Mass Spectroscopy
6.3.1. Mass Spectroscopy Market, 2018 – 2030 (USD Million)
6.4. In Situ Hybridization
6.4.1. In Situ Hybridization Market, 2018 – 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 – 2030 (USD Million)
Chapter 7. Bloodstream Infection Testing Market: End-User Business Analysis
7.1. Bloodstream Infection Testing Market: End-User Movement Analysis
7.2. Hospitals & Diagnostic Centers
7.2.1. Hospitals & Diagnostics Centers Market, 2018 – 2030 (USD Million)
7.3. Custom Laboratory Service Providers
7.3.1. Custom Laboratory Service Providers Market, 2018 – 2030 (USD Million)
7.4. Academic & Research Institutes
7.4.1. Academic & Research Institutes Market, 2018 – 2030 (USD Million)
7.5. Others
7.5.1. Others Market, 2018 – 2030 (USD Million)
Chapter 8. Bloodstream Infection Testing Market: Regional Business Analysis
8.1. Bloodstream Infection Testing Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. SWOT Analysis
8.2.2. North America Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.2.3. U.S.
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. Reimbursement Scenario
8.2.3.6. U.S. Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.2.4. Canada
8.2.4.1. Key Country Dynamics
8.2.4.2. Target Disease Prevalence
8.2.4.3. Competitive Scenario
8.2.4.4. Regulatory Framework
8.2.4.5. Reimbursement Scenario
8.2.4.6. Canada Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.3. Europe
8.3.1. Europe Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Target Disease Prevalence
8.3.2.3. Competitive Scenario
8.3.2.4. Regulatory Framework
8.3.2.5. Reimbursement Scenario
8.3.2.6. UK Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Target Disease Prevalence
8.3.3.3. Competitive Scenario
8.3.3.4. Regulatory Framework
8.3.3.5. Reimbursement Scenario
8.3.3.6. Germany Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Target Disease Prevalence
8.3.4.3. Competitive Scenario
8.3.4.4. Regulatory Framework
8.3.4.5. Reimbursement Scenario
8.3.4.6. France Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Target Disease Prevalence
8.3.5.3. Competitive Scenario
8.3.5.4. Regulatory Framework
8.3.5.5. Reimbursement Scenario
8.3.5.6. Italy Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Target Disease Prevalence
8.3.6.3. Competitive Scenario
8.3.6.4. Regulatory Framework
8.3.6.5. Reimbursement Scenario
8.3.6.6. Spain Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Target Disease Prevalence
8.3.7.3. Competitive Scenario
8.3.7.4. Regulatory Framework
8.3.7.5. Reimbursement Scenario
8.3.7.6. Denmark Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Target Disease Prevalence
8.3.8.3. Competitive Scenario
8.3.8.4. Regulatory Framework
8.3.8.5. Reimbursement Scenario
8.3.8.6. Sweden Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Target Disease Prevalence
8.3.9.3. Competitive Scenario
8.3.9.4. Regulatory Framework
8.3.9.5. Reimbursement Scenario
8.3.9.6. Norway Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Target Disease Prevalence
8.4.2.3. Competitive Scenario
8.4.2.4. Regulatory Framework
8.4.2.5. Reimbursement Scenario
8.4.2.6. Japan Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Competitive Scenario
8.4.3.4. Regulatory Framework
8.4.3.5. Reimbursement Scenario
8.4.3.6. China Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Competitive Scenario
8.4.4.4. Regulatory Framework
8.4.4.5. Reimbursement Scenario
8.4.4.6. India Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Target Disease Prevalence
8.4.5.3. Competitive Scenario
8.4.5.4. Regulatory Framework
8.4.5.5. Reimbursement Scenario
8.4.5.6. Australia Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.4.6. Thailand
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Regulatory Framework
8.4.6.5. Reimbursement Scenario
8.4.6.6. Thailand Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.4.7. South Korea
8.4.7.1. Key Country Dynamics
8.4.7.2. Target Disease Prevalence
8.4.7.3. Competitive Scenario
8.4.7.4. Regulatory Framework
8.4.7.5. South Korea Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Target Disease Prevalence
8.5.2.3. Competitive Scenario
8.5.2.4. Regulatory Framework
8.5.2.5. Reimbursement Scenario
8.5.2.6. Brazil Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Competitive Scenario
8.5.3.4. Regulatory Framework
8.5.3.5. Reimbursement Scenario
8.5.3.6. Mexico Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Competitive Scenario
8.5.4.4. Regulatory Framework
8.5.4.5. Reimbursement Scenario
8.5.4.6. Argentina Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.6. MEA
8.6.1. MEA Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Target Disease Prevalence
8.6.2.3. Competitive Scenario
8.6.2.4. Regulatory Framework
8.6.2.5. Reimbursement Scenario
8.6.2.6. South Africa Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Competitive Scenario
8.6.3.4. Regulatory Framework
8.6.3.5. Reimbursement Scenario
8.6.3.6. Saudi Arabia Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Competitive Scenario
8.6.4.4. Regulatory Framework
8.6.4.5. Reimbursement Scenario
8.6.4.6. UAE Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Competitive Scenario
8.6.5.4. Regulatory Framework
8.6.5.5. Reimbursement Scenario
8.6.5.6. Kuwait Bloodstream Infection Testing Market, 2018 – 2030 (USD Million)
Chapter 9. Bloodstream Infection Testing Market: Competitive Landscape
8.1. Participant Categorization
9.1.1. bioMérieux SA
9.1.1.1. Overview
9.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.1.3. Product Benchmarking
9.1.1.4. Strategic Initiatives
9.1.2. BD
9.1.2.1. Overview
9.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.2.3. Product Benchmarking
9.1.2.4. Strategic Initiatives
9.1.3. Cepheid
9.1.3.1. Overview
9.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.3.3. Product Benchmarking
9.1.3.4. Strategic Initiatives
9.1.4. Seegene Inc.
9.1.4.1. Overview
9.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.4.3. Product Benchmarking
9.1.4.4. Strategic Initiatives
9.1.5. T2 Biosystems, Inc.
9.1.5.1. Overview
9.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.5.3. Product Benchmarking
9.1.5.4. Strategic Initiatives
9.1.6. F. Hoffmann-La Roche Ltd
9.1.6.1. Overview
9.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.6.3. Product Benchmarking
9.1.6.4. Strategic Initiatives
9.1.7. Siemens Healthcare Limited
9.1.7.1. Overview
9.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.7.3. Product Benchmarking
9.1.7.4. Strategic Initiatives
9.1.8. Luminex Corporation
9.1.8.1. Overview
9.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.8.3. Product Benchmarking
9.1.8.4. Strategic Initiatives
9.1.9. Bruker
9.1.9.1. Overview
9.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.9.3. Product Benchmarking
9.1.9.4. Strategic Initiatives
9.1.10. Accelerate Diagnostics, Inc.
9.1.10.1. Overview
9.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.10.3. Product Benchmarking
9.1.10.4. Strategic Initiatives
9.2. Participant’s Overview
9.3. Financial Performance
9.4. Product Benchmarking
9.5. Company Market Share Analysis, 2022
9.6. Strategy Mapping
9.6.1. Expansion
9.6.2. Acquisition
9.6.3. Product/Service Launch
9.6.4. Others
Chapter 10. Analyst View

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Bloodstream Infection Testing Market, By Product, 2018 - 2030 (USD Million)
Table 4 Global Bloodstream Infection Testing Market, By Sample type, 2018 - 2030 (USD Million)
Table 5 Global Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
Table 6 Global Bloodstream Infection Testing Market, By End-user, 2018 - 2030 (USD Million)
Table 7 Global Bloodstream Infection Testing Market, By Region, 2018 - 2030 (USD Million)
Table 8 North America Bloodstream Infection Testing Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America Bloodstream Infection Testing Market, By Product, 2018 - 2030 (USD Million)
Table 10 North America Bloodstream Infection Testing Market, By Sample type, 2018 - 2030 (USD Million)
Table 11 North America Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
Table 12 North America Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 13 U.S. Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 14 U.S. Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 15 U.S. Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
Table 16 U.S. Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 17 Canada Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 18 Canada Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 19 Canada Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
Table 20 Canada Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD million)
Table 21 Europe Bloodstream Infection Testing market, by Country, 2018 - 2030 (USD Million)
Table 22 Europe Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 23 Europe Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
Table 24 Europe Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 25 Europe Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 26 UK Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 27 UK. Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 28 UK Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
Table 29 UK Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 30 Germany Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 31 Germany Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 32 Germany Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 33 Germany Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 34 France Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 35 France Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 36 France Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 37 France Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 38 Italy Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 39 Italy Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 40 Italy Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 41 Italy Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 42 Spain Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 43 Spain Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 44 Spain Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 45 Spain Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 46 Denmark Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 47 Denmark Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 48 Denmark Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 49 Denmark Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 50 Sweden Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 51 Sweden Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 52 Sweden Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 53 Sweden Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 54 Norway Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 55 Norway Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 56 Norway Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 57 Norway Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Bloodstream Infection Testing market, by Country, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 63 Japan Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 64 Japan Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 65 Japan Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 66 Japan Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 67 China Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 68 China Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 69 China Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 70 China Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 71 India Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 72 India Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 73 India Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 74 India Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 75 Australia Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 76 Australia Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 77 Australia Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 78 Australia Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 79 Thailand Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 80 Thailand Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 81 Thailand Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 82 Thailand Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 83 South Korea Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 84 South Korea Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 85 South Korea Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 86 South Korea Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 87 Latin America Bloodstream Infection Testing market, by Country, 2018 - 2030 (USD Million)
Table 88 Latin America Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 89 Latin America Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 90 Latin America Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 91 Latin America Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 92 Brazil Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 93 Brazil Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 94 Brazil Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 95 Brazil Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 96 Mexico Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 97 Mexico Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 98 Mexico Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 99 Mexico Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 100 Argentina Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 101 Argentina Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 102 Argentina Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 103 Argentina Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Bloodstream Infection Testing market, by Country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 109 South Africa Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 110 South Africa Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 111 South Africa Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 112 South Africa Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 117 UAE Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 118 UAE Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 119 UAE Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 120 UAE Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
Table 121 Kuwait Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 122 Kuwait Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
Table 123 Kuwait Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
Table 124 Kuwait Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の血流感染検査市場2023-2030：製品別（機器、試薬、消耗品）、サンプル種類別（血液培養）、技術別（PCR、ISH）、エンドユーザー別、地域別(Bloodstream Infection Testing Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Sample Type (Blood Culture), By Technology (PCR, ISH), By End-user, By Region, And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の血流感染検査市場2023-2030：製品別（試薬・消耗品、機器）、サンプル種類別（全血、血液培養）、技術別（PCR、質量分析、インサイチュハイブリダイゼーション、その他）、エンドユース別（病院・診断センター、カスタムラボサービスプロバイダー、その他）、地域別
  • 尿路感染症検査の世界市場（2023年～2030年）：市場規模、シェア、動向分析
  • 着床前遺伝子検査（PGT）のグローバル市場2023-2030：PGD、PGS
  • 着床前遺伝子検査（PGT）のグローバル市場2023-2030：試薬・消耗品、機器、ソフトウェア
  • 世界のELISA法分析器市場2023-2030：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆